QIONG WANG: Open Payments
NPI 1871018713 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 12 payments from 6 companies in 2025. Trend: 2023 $200 · 2024 $70 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $202 |
| Dexcom, Inc. | 2 | $165 |
| Exact Sciences Corporation | 2 | $47 |
| Astellas Pharma US Inc | 1 | $30 |
| PFIZER INC. | 1 | $26 |
| ABBVIE INC. | 1 | $20 |
Products named: DEXCOM G7 GSS (161), Vemlidy, Cologuard Collection Kit, Veozah, PREVNAR 20, Dexcom G6 Transmitter, QULIPTA.
Industry payments across VA — which companies pay providers there.
